Correction to: Acta Pharmacologica Sinica https://doi.org/10.1038/s41401-019-0287-8, published online 23 August 2019; https://doi.org/10.1038/s41401-019-0281-1, published online 01 August 2019
The articles listed above were initially published with incorrect copyright information or changed later to incorrect copyright information.
Upon publication of this Correction, the copyright of these articles changed to “The Author(s)”.
The original articles have been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhong, Hh., Wang, Hy., Gao, J. et al. Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’. Acta Pharmacol Sin 42, 843 (2021). https://doi.org/10.1038/s41401-020-0444-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-020-0444-0
